Although not with statistically significant difference, BAT6026 showed a trend of stronger anti-tumor effect in the OX40-humanized mice model than BAT6026-wt (TGI 38.3% versus 21.1%) (data not shown). The gene discussed is TNFRSF4; the disease is neoplasm.